A Phase 2 Multicenter Single arm Study of Moxetumomab Pasudotox in Pediatric Subjects with Relapsed or Refractory pALL
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
MedImmune, Inc.
Start Date
May 1, 2014
End Date
April 30, 2016
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
MedImmune, Inc.
Start Date
May 1, 2014
End Date
April 30, 2016